Back

Objectively measured prevalence and time trends of obesity and severe obesity in 447 925 Swedish adults, 1995-2017

12 April 2019 (10:00 - 11:00)
Organised by:
Congress Presentation Part of: Moderated Posters Session 3 Obesity EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Professor Bjorn Ekblom

Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Small-molecule mediated chemical knock-down of MuRF1 attenuates diaphragm dysfunction in chronic heart failure
Doctor V. Adams (Dresden, DE)
Abstract
Presentation thumbnail
Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a CMD prevention program
Mrs D. Stol (Utrecht, NL)
Abstract
Presentation thumbnail
Features of expression and concentration of adiponectin in adipocytes of adipose tissue of different localization in patients with ischemic heart disease
Doctor Y. Dyleva (Kemerovo, RU)
Abstract
Presentation thumbnail
Effect of a family based randomized controlled trial of cardiovascular risk reduction in individuals with premature family history of coronary heart disease: One-year results of PROLIFIC study.
Doctor J. Panniyammakal (Thiruvananthapuram, IN)
Abstract
Presentation thumbnail
miR-1 and miR-133b are associated with failed myocardial reperfusion and worse left ventricular functional recovery in STEMI patients
Doctor J. Coelho Lima Junior (Cambridge, GB)
Abstract Slides

Access the full session

Session thumbnail
Moderated Posters Session 3

The Event

Event poster

EuroPrevent 2019

12 April 2019 10:00 CET
You may be interested in
thumbnail
Congress Presentation
What characterizes normotensive individuals with obesity and normal systolic heart function? A descriptive study from the SCAPIS cohort
1 September 2024
thumbnail
Congress Presentation
Prevalence and temporal trends of risk factors among young patients with acute myocardial infarction - a nationwide cohort study
30 August 2024
thumbnail
Congress Presentation
Ablation outcome and post-interventional management of anticoagulation in patients with obesity or severe obesity and atrial fibrillation
13 April 2026
thumbnail
Congress Presentation
Cardiovascular outcomes in a SELECT-like obesity population: real-world insights from the swedish AROS study
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources